U.S. markets closed
  • S&P Futures

    4,511.75
    +0.50 (+0.01%)
     
  • Dow Futures

    35,335.00
    +12.00 (+0.03%)
     
  • Nasdaq Futures

    15,390.50
    -8.00 (-0.05%)
     
  • Russell 2000 Futures

    2,272.30
    -0.50 (-0.02%)
     
  • Crude Oil

    83.05
    +0.09 (+0.11%)
     
  • Gold

    1,768.50
    -2.00 (-0.11%)
     
  • Silver

    23.65
    -0.24 (-1.00%)
     
  • EUR/USD

    1.1635
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.6350
    +0.0510 (+3.22%)
     
  • Vix

    15.70
    -0.61 (-3.74%)
     
  • GBP/USD

    1.3794
    0.0000 (-0.00%)
     
  • USD/JPY

    114.6620
    +0.3020 (+0.26%)
     
  • BTC-USD

    64,041.29
    +1,895.66 (+3.05%)
     
  • CMC Crypto 200

    1,483.45
    +20.09 (+1.37%)
     
  • FTSE 100

    7,217.53
    +13.70 (+0.19%)
     
  • Nikkei 225

    29,406.32
    +190.80 (+0.65%)
     

Alpine Immune Sciences, Inc. (ALPN) Moves 9.5% Higher: Will This Strength Last?

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Alpine Immune Sciences, Inc. ALPN shares rallied 9.5% in the last trading session to close at $15.03. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 24.6% gain over the past four weeks.

Shares sruged as investors continue to be upbeat about the company's pipeline progress and upcoming data readouts.

Price and Consensus

Price Consensus Chart for ALPN
Price Consensus Chart for ALPN

This company is expected to post quarterly loss of $0.26 per share in its upcoming report, which represents a year-over-year change of +50.9%. Revenues are expected to be $7.72 million, up 1018.1% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For Alpine Immune Sciences, Inc., the consensus EPS estimate for the quarter has been revised 20% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on ALPN going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Alpine Immune Sciences, Inc. (ALPN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research